Why I am Not Accomplishing Laser Treatment for Vaginal Atrophy

This transcript has been edited for clarity.

Symptomatic vaginal atrophy is popular in menopausal women, and without the need of therapy, it tends to development. Not too long ago, some medical professionals have been providing carbon dioxide laser as an substitute to vaginal estrogen in the treatment method of this issue. Even so, the efficacy of laser for this indicator has been unsure.

Investigators at an Australian training medical center randomized women of all ages with menopausal signs or symptoms suggesting vaginal atrophy to laser or sham treatment. Members underwent a few therapies at regular monthly intervals.

Laser treatments were being performed with regular settings whilst sham treatment plans were being conducted with small configurations that have no tissue effect. Community anesthesia product was employed for all strategies, as was a plume evacuator to minimize visual and olfactory clues from laser smoke.

To retain blinding, unique clinicians done assessments and remedies. Transform in severity of signs and symptoms, which includes dyspareunia, dysuria, vaginal dryness, burning, and itching, was assessed at 12 months. Vaginal biopsies were being carried out at baseline and 6 months right after therapy.

Amongst 78 members with 12-thirty day period evaluations, the mean age was 57, and approximately 50 % were being sexually active.

For the laser and sham groups, at 12 months, no significant dissimilarities have been observed for alter in overall signs or in the most intense symptom. Also, the proportion of participants who noted a reduction of increased than 50% in hassle from their most severe signs or symptoms was identical in the two teams. In addition, adjustments in vaginal histology have been similar in the laser and sham teams.

Finally, the proportion of participants who described adverse events, such as transient vaginal discomfort, discharge, or urinary tract signs, was equivalent in the two groups.

Though other randomized studies of vaginal laser in the procedure of menopausal signs have prompt that laser is as effective as vaginal estrogen in addressing menopausal signs or symptoms, this Australian demo is the longest to day and also the initial to use sham-addressed controls. My takeaway from this thoroughly executed examine is that outside the house of clinical trials, we need to neither advise nor complete laser for procedure of menopausal vaginal signs and symptoms.

Thank you for the honor of your time. I am Andrew Kaunitz.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube